Quarterly report pursuant to Section 13 or 15(d)

Schedule of Capitalized Technology (Details)

v3.22.1
Schedule of Capitalized Technology (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Research and Development [Abstract]    
Balance, beginning of period $ 43,038 $ 25,867
Additional capitalized cost 49,970
Provision for amortization (4,392) (32,799)
Balance, end of period $ 38,646 $ 43,038